The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Michigan Newborn Screening Information - Severe Combined Immunodeficiency (SCID)
SCID represents a group of more than 13 inherited disorders that lack functional T and B cells responsible for cellular and humoral immunity, respectively. Newborns with SCID are unable to mount an immune response to infection by viruses, bacteria and fungi. They become severely ill during the first year of life and rarely survive beyond the second year. However, if detected early by newborn screening, infants with SCID can be successfully treated by bone marrow transplantation.
Newborn Screening News - Summer 2011
Quick Links
- Letter to Directors of Pediatrics, Special Care Nurseries and Neonatal Intensive Care Units
- Letter to Clinical Laboratory Directors
- Press Release: MDCH Adds Severe Combined Immunodeficiency (SCID) to Newborn Screening
- SCID Newborn Screening ACT Sheet
Additional Information
About Primary Immunodeficiency Diseases
Primary Immunodeficiency Resource Center
Immune Deficiency Foundation